Population genomics of pneumococcal carriage in South Africa following the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) immunization

被引:7
|
作者
Javaid, Nida [1 ,2 ]
Olwagen, Courtney [3 ,4 ]
Nzenze, Susan [3 ,4 ]
Hawkins, Paulina [5 ]
Gladstone, Rebecca [2 ]
McGee, Lesley [5 ]
Breiman, Robert F. [6 ]
Bentley, Stephen D. [2 ,7 ]
Madhi, Shabir A. [3 ,4 ]
Lo, Stephanie [2 ]
机构
[1] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan
[2] Wellcome Sanger Inst, Parasites & Microbes, Hinxton, England
[3] Univ Witwatersrand, Natl Res Fdn Vaccine Preventable Dis, Dept Sci & Technol, Johannesburg, South Africa
[4] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Med Res Council Resp & Meningeal Pathogens Res Un, Johannesburg, South Africa
[5] Ctr Dis Control & Prevent, Atlanta, GA USA
[6] Emory Global Hlth Inst, Atlanta, GA USA
[7] Univ Cambridge, Dept Pathol, Cambridge, England
来源
MICROBIAL GENOMICS | 2022年 / 8卷 / 06期
关键词
antimicrobial resistance; pneumococci; pneumococcal carriage; pneumococcal conjugate vaccine; pneumococcal genomics; TEMPORAL-CHANGES; COLONIZATION; DISEASE;
D O I
10.1099/mgen.0.000831
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Streptococcus pneumoniae is a major human pathogen responsible for over 317000 deaths in children <5 years of age with the burden of the disease being highest in low-and middle-income countries including South Africa. Following the introduction of the 7-valent and 13-valent pneumococcal conjugate vaccine (PCV) in South Africa in 2009 and 2011, respectively, a decrease in both invasive pneumococcal infections and asymptomatic carriage of vaccine -type pneumococci were reported. In this study, we described the changing epidemiology of the pneumococcal carriage population in South Africa, by sequencing the genomes of 1825 isolates collected between 2009 and 2013. Using these genomic data, we reported the changes in serotypes, Global Pneumococ-cal Sequence Clusters (GPSCs), and antibiotic resistance before and after the introduction of PCV13. The pneumococcal carriage population in South Africa has a high level of diversity, comprising of 126 GPSCs and 49 serotypes. Of the ten most prevalent GPSCs detected, six were predominantly found in Africa (GPSC22, GPSC21, GPSC17, GPSC33, GPSC34 and GPSC52). We found a significant decrease in PCV7 serotypes (19F, 6B, 23F and 14) and an increase in non-vaccine serotypes (NVT) (16F, 34, 35B and 11A) among children <2 years of age. The increase in NVTs was driven by pneumococcal lineages GPSC33, GPSC34, GPSC5 and GPSC22. Overall, a decrease in antibiotic resistance for 11 antimicrobials was detected in the PCV13 era. Further, we reported a higher resistance prevalence among vaccine types (VTs), as compared to NVTs; however, an increase in penicillin resistance among NVT was observed between the PCV7 and PCV13 eras. The carriage isolates from South Africa predominantly belonged to pneumococcal lineages, which are endemic to Africa. While the introduction of PCV resulted in an overall reduction of resistance in pneumococcal carriage isolates, an increase in penicillin resistance among NVTs was detected in children aged between 3 and 5 years, driven by the expan-sion of penicillin-resistant clones associated with NVTs in the PCV13 era.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] THE COST-EFFECTIVENESS ANALYSIS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) AND 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) IN TAIWAN
    Wu, D. B. C.
    Chang, C. J.
    Chien, L.
    Fang, H. C. H.
    Roberts, C. S.
    VALUE IN HEALTH, 2012, 15 (07) : A602 - A602
  • [22] THE COST-EFFECTIVENESS OF THE NEW PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (PCV13) FOR CHILDHOOD AND ADULT VACCINATION IN THE UK
    Patel, R.
    Stoykova, B.
    Lloyd, A. C.
    Willingham, J.
    Hollingsworth, R.
    VALUE IN HEALTH, 2009, 12 (07) : A427 - A427
  • [23] Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Solid Organ Transplant (SOT) Candidates and Recipients
    Sun, H.
    Liu, W.
    Su, Y.
    Ho, C.
    Hu, R.
    Chou, N.
    Wang, S.
    Hsu, H.
    Hung, C.
    Chang, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 770 - 771
  • [24] Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Solid Organ Transplant (SOT) Candidates and Recipients
    Sun, H.
    Liu, W.
    Su, Y.
    Ho, C.
    Hu, R.
    Chou, N.
    Wang, S.
    Hsu, H.
    Hung, C.
    Chang, S.
    TRANSPLANTATION, 2014, 98 : 770 - 771
  • [25] Pneumococcal Carriage in Burkina Faso After 13-Valent Pneumococcal Conjugate Vaccine Introduction and Before a Schedule Change
    Childs, Lana
    Ouedraogo, Issa
    Zoma, Robert Lamoussa
    Tarbangdo, T. Felix
    Sawadogo, Guetwende
    Ake, H. Flavien
    Ouangraoua, Soumeya
    Sanou, Soufiane
    Tran, Theresa
    Velusamy, Srinivasan
    Adebanjo, Tolulope
    Van Beneden, Chris A.
    Mcgee, Lesley
    Kobayashi, Miwako
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (06):
  • [26] Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3+1 schedule
    Syrogiannopoulos, George A.
    Grivea, Ioanna N.
    Moriondo, Maria
    Nieddu, Francesco
    Michoula, Aspasia N.
    Calabrese, Maria Rita
    Anthracopoulos, Michael
    Azzari, Chiara
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [27] Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults
    Atwood, Mark
    Beausoleil, Linda
    Breton, Marie-Claude
    Laferriere, Craig
    Sato, Reiko
    Weycker, Derek
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2018, 109 (5-6): : 756 - 768
  • [28] COST-EFFECTIVENESS ANALYSIS OF SEQUENTIAL VACCINATION OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) AND 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV23) ON ADULT POPULATION IN SOUTH KOREA
    Park, D.
    Kang, S.
    VALUE IN HEALTH, 2017, 20 (09) : A788 - A788
  • [29] Impaired response to 13-valent pneumococcal conjugate vaccine (PCV13) in children with recurrent respiratory infections and chronic cough
    Elashmawy, Moataz
    Baker, James
    Polychronakis, Theofilos
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [30] One-step multiplex PCR for rapid identification of 13-valent pneumococcal conjugate vaccine (PCV13) serotypes
    Ari, Fatma Filiz
    Durmaz, Riza
    Guldemir, Dilek
    Otgun, Selin
    Acar, Bulent
    Ertek, Mustafa
    CURRENT OPINION IN BIOTECHNOLOGY, 2011, 22 : S108 - S109